Let ProteinSimple Help You Get Your Biosimilars to Market
Biopharmaceuticals represent one of the fastest growing segments of the drug market, with over 100 billion dollars in annual sales. The development of biosimilars – biotherapeutic products similar to previously licensed reference biotherapeutic products in terms of quality, safety and efficacy– therefore represents a prime opportunity as the innovator biologics go off patent.
Get Charge Heterogeneity and Size Data with Maurice
Maurice, our next-gen capillary electrophoresis system, combines both imaged capillary isoelectric focusing (icIEF) and capillary electrophoresis sodium dodecyl sulfate (CE-SDS) detection schemes in a single, automated platform. Get method development in hours, not weeks, with Maurice. He also enables platform methods which can be applied to a variety of protein molecules.
Evaluate Biosimilar Stability with MFI
Micro-Flow Imaging (MFI) directly images subvisible particles in solution. With its ability to capture data on 10 different morphological parameters and its powerful analysis software, MFI can detect and differentiate between particle subpopulations, including translucent protein aggregates, which can often be missed by other particle detection methods.